RGSE will provide upside guideance when they announce earnings. May have to be patient while they take care of the accounting aspects of aquiring Mercury, but the outlook is guaratneed to be very bullish. I also expect another aquisition announcement. Mofid has plans to rival and compete head to head with SCTY.
Easily - and it will mark the start of a sustained run. The company has not issued a single update on growth projections since all of the partnership announcements. Expect tomorrow to be the first glimpse of how significantly these deals are going to grow the number of tests and revenue. Also expect to hear about expansion plans for the business - and other partnerships to come.
My advice to shorts... time to flip. This isn't going to continue the pattern of dropping on news - not when revenue projections or actuals are behind the momentum.
for CBMX to have signed all of these deals and not see a significant uptick in tests performed. Look for blow out numbers and forecast from these guys very soon. They have cash and are using it to hire can ramp up production. Not one of these health care providers would sign a contract with CBMX without knowing they could handle the volume... and based on the size of these providers, there is going to be significant volume. they were already trending up in test volume - look for a very sharp rise going forward. hang in there - this will be significantly higher as the earnings date approaches.. unless they issue forecast numbers sooner.
You don't go through all the negotiation and legal wrangling associated with these contracts unless there is demand for the product. If you look at all of the recent contract wins, and the millions of people covered - this is absolutely going to translate into substantial growth. The financing is to expand the business and capacity. One of the PR's coming in the very near future is going to be about growth projections based on the new contracts. You saw how easily this broke 4... I suspect there will be a significant pop on that announcement followed by a steady climb as the cycle breaks and short players get stuck.
Absolutely worth a gamble at this price. Not sure why anyone would remain short on a stock in the $2 range - solar is just starting it's rebound. Not to mention it is 100% accurate that RSOL will be likened to SCTY more and more as SCTY continues it's climb. RSOL is on an aquisition trail with a plan to either compete head to head with SCTY - or be bought by them. If you remember, these guys can't keep up with demand because they need more engineers - recent financing was to hire the engineers and look for another buyout target. No doubt in my mind this will be over $5 next year... and quickly if the shorts hang around.
Someone had to dump 1000 shares after hours and caused a minor following - cheap shares, too bad I wasn't online to snap them up. News from these guys is coming shortly. Their volume of tests is going to grow significantly with all the new partners... and publicity.